In this monthly column called “The deal tracker,” we look at major funding events that took place in China’s robotic sector the previous month and rank them in a chronological order.
Compared to multi-incision surgical robot, single-port system is a harder nut to crack as it leaves a single cut in the patient's abdomen.
What's more, the device also made history by becoming the first assistive surgical system to undertake clinical trials in pelvis facture recovery, he added at the conference.
Zhuhai is part of the Guangdong-Hong Kong-Macao Greater Bay Area, attracting a number of startups to put down roots in Hengqin, a special economic zone of the mainland Chinese city that is partly governed by Macao.
The product has passed the type inspection required of medical equipment within China, and was successfully applied in live animal tests on rabbit and monkey, pending registered clinical trial.
The white paper states that Beijing has a rich pool of technological resources that underpin the city's ambitions to construct a smart medical and healthcare robotics sector.
This development also made Monarch the first minimally invasive RAS platform for medical procedures on lungs and bronchus to be officially licensed in China.
From then on, this prized product, which has become a benchmark for surgical robots across the world, will enter Chinese hospitals as homegrown medical equipment, potentially giving it an edge in price.
China's surgical robot market is experiencing fast growth thanks to higher adoption of minimally invasive robot-assisted surgeries (RAS) and medical insurance coverage that lowers the resulting financial burden on patients and their families.
It represents the transition of the industry from a laggard trying to catch up with market incumbents to a world-class player with a knack for its own disruptive innovations.
By the end of 2025, the city will possess 10 application scenarios for medical robotics that can be replicated and promoted nationwide, the plan adds.
This could herald price cuts and higher penetration for robot-assisted surgeries (RAS) in China's hospitals.
Trending posts in the last week
Prefecture-level city under Hangzhou earmarks US$700m to build ‘robot town’
Shandong maps out path to US$1.4b in drone industry output by 2025
Movers and shakers: Who raised funds in November 2023 and who are they?
Unmanned chopper builder FlightWin bags US$14m in Series B+ raise